AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT01731951 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Imetelstat
Description: Imetelstat sodium administered as IV over 2 hours with treatment as long as participants derive clinical benefit or until end of study.
Study NCT02079077 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Acetylsalicylic Acid (ASA)
Description: Acetylsalicylic Acid (ASA) 81 mg. oral daily for two months
Study NCT02079077 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Hydroxychloroquine (HCQ)
Description: Hydroxychloroquine (HCQ) 200 mg. oral, daily for two months.
Study NCT04246918 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Branched Chain Amino Acid
Description: Branched chain amino acid is a group of three amino acids known for there role in muscle growth.
Study NCT04246918 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Whey Protein concentrate powder
Description: Whey protein will be given to the standard treatment arm including in the same amount of 1.5gm/kg/IBW.
Study NCT01631123 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Isocaloric high carbohydrate diet intervention
Description: Time of 6 week, the last 6 days are standardized
Study NCT01631123 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Isocaloric high fat diet intervention
Description: Time of 6 weeks; the first and the last 6 days are standardized
Study NCT00658918 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ciclesonide nasal
Description: safety of Ciclesonide (200µg, 100µg, 25µg)
Study NCT00658918 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: placebo
Study NCT01404546 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: usual care
Description: Participants assigned to the prescription only usual care group received a prescription for smoking cessation pharmacotherapy to be filled at their own cost at their local community pharmacy.
Study NCT04279210 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma
Description: The RegenKit-THT (RegenLab SA, Switzerland) was used to separation of plasma and blood cells. 3mL PRP was extracted from the bottom of the plasma. PRP was injected into anterior vaginal wall, near external urethral sphincter, and into endopelvic fascia.
Study NCT00610129 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MK-0646
Description: MK-0646 (20 mg/mL) in sterilized solution for IV infusion (12.7 mL to deliver 12.0 mL) will be used for a dose of 10 mg/kg IV weekly administered over 60 minutes.
Study NCT00634699 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Active Comparator, ischemic compressions
Description: Ischemic Compressions,3 times a week,5 weeks.
Study NCT03884985 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Visual stimulation
Description: In the experiments, participants will sit in front of a computer monitor located a less than a meter of distance and will analyze the content of images extracted from collections of natural and computer-generated scenes. Subjects will be asked to report verbally or by pressing keys on a keyboard on image characteristics such as the locations of the objects present in the scenes, their number and/or their identities. Some experiments will involve a search paradigm in which subjects will have to report on the location and/or fine characteristics of a target element among a field of distracting similar elements, and/or visual discrimination tasks. The duration of the interval of time in which the image is maintained on the screen may be varied between few tens of milliseconds to several seconds. In a set of experiments, the eye movements performed by the subjects during the execution of the visual tasks will be recorded as explained below.
Study NCT05115175 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Stress Reduction
Description: Participants engaged in meditation and self-led exercises to help them understand and cope with stress.
Study NCT00710268 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AZD2281
Description: Oral Capsule, Dose Escalation 50, 100, 200, 400 mgContinuous twice daily dosing
Study NCT00710268 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bevacizumab
Description: IV administration10 mg/kg every 14 days
Study NCT02470481 — intervention group
Intervention type: OTHER
Intervention: No Intervention
Description: This is an obervational study
Study NCT00349869 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: yoga
Description: 8-week yoga program.
Study NCT00945815 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: epratuzumab
Study NCT00945815 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: clofarabine
Study NCT00945815 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cytarabine
Study NCT00945815 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: laboratory biomarker analysis
Study NCT01803958 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: whole breast irradiation
Study NCT00816816 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: docetaxel, cisplatin, fluorouracil
Description: neoadjuvant chemotherapy: docetaxel 75 mg/m2 on day 1; cisplatin 75 mg/m2 on day 1; and a continuous fluorouracil infusion at 500 mg/m2/d on days 1 through 5.~concurrent chemotherapy:cisplatin 40 mg/m2 weekly.
Study NCT02646878 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Harmony 1 Sensor
Description: Use of Harmony 1 Sensor for 10 days when inserted in the arm and abdomen and used with the Guardian Mobile in subjects aged 14-75 years who have had a diagnosis of type 1 or type 2 diabetes for at least 6 months.
Study NCT01956396 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: PrePex™ device
Description: PrePex™ device for adult male circumcision. The non-surgical PrePex™ device with No Injected Anesthesia
Study NCT04462159 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Risk Reduction Program
Description: Education, exercise, teaching kitchen and nutrition, and psychological support
Study NCT04442932 — intervention group
Intervention type: DEVICE
Intervention: Blood Collection
Description: K3-EDTA venous whole blood 9 mL 1 venous draw
Study NCT03696342 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pazufloxacin
Description: Pazufloxacin 0.6%. by Sophia Laboratories, topical ophthalmic~1 drop, 3 times a day during the waking period in both eyes (at approximate intervals of 6 hours), for 7 days.
Study NCT02791906 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ISMN
Study NCT02791906 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Vitamin C
Study NCT01784172 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: electroacupuncture group
Description: Procedure: electro-acupuncture;Points: Bilateral Zhongliao (BL33) Huiyang(BL35).Specially-made pad is stick on pierced acupoints. Bilateral BL33 are given acupuncture of 50～60mm with 30～45°angle to inward and downward by 75mm filiform needle. Bilateral BL35 are given acupuncture of 50～60mm to outward and upward by 75mm filiform needle. Twirl, lift and thrust for 3 times, until local sour and heavy feeling coming.The electric stimulator is applied to bilateral BL33 and BL35, with continuous wave,50 Hz and electric current 1- 5mA.Every session lasts for 30 min per day.The participants are treated continuously for 6 weeks for 3 sessions a week, 18 sessions for each patient in all. The treatment is designed based on recent literature research in 10 years, former result and expert consensus.
Study NCT01784172 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: sham electroacupuncture group
Description: Procedure: sham electroacupuncture;Points: Bilateral sham Zhongliao (BL33) sham Huiyang(BL35).Specially-made pad is stick on pierced acupoints. Both sham BL33 and BL35 are given non-penetrating needling with blunt needle. Twirl, lift and thrust for 3 times. The sham electric stimulator is applied to bilateral sham BL33 and sham BL35. The mental wire has been cut off with a same outlook as the treatment group. The electric stimulator is looked normal but with no current output. Length of Treatment and the treatment sessions are the same as treatment group.
Study NCT03048175 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Wisdom tooth removal
Description: After inferior dental and buccal nerve anesthesia a triangular full thickness flap with releasing incision on the mesio-buccal aspect of the second molar is designed. Ostectomy is then performed and tooth is sectioned and gently elevated. Once all the tooth components are extracted, the socket is carefully inspected and flap is sutured with interrupted sutures.
Study NCT02210026 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Seattle-PAP
Description: We propose to test the hypothesis that by introduction of variation in airway pressure Seattle bubble nasal continuous positive airway pressure (Seattle-PAP) reduces work of breathing in very low birth weight infants more effectively than standard bubble nasal continuous positive airway pressure.
Study NCT01428570 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Pentax-AWS (AWS; Pentax Corporation, Tokyo, Japan)
Description: Each group of patients will be intubated using the Macintosh laryngoscope or Pentax-AWS.
Study NCT01428570 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Pentax-AWS (AWS; Pentax Corporation, Tokyo, Japan)
Description: Each group of patients will be intubated using the Macintosh laryngoscope or Pentax-AWS.
Study NCT04162717 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: The Effect of Telephone Symptom Triage Protocols on Symptom Management, Quality of Life and Self-Care Maintenance in Patients with Cancer Who Applied Systemic Treatment
Description: Symptom management, quality of life and self-maintenance were assessed by scales at the first interview and 3 months later.~Intervention group received symptom triage application with telephone, which consisted of guiding in line with symptom triage protocols. The patients who were included in the intervention were followed up by telephone on the 3rd, 7th and 10th day of after chemotherapy total of nine times during three chemotherapy cycles.
Study NCT04227665 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Sea level
Description: Sea level exposure / sea level exposure combined with microdoses of rHuEPO
Study NCT04227665 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Altitude
Description: Altitude exposure / altitude exposure Iron metabolism
Study NCT04422145 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Structured nurse led intervention programme
Description: A diabetes research nurse, over a period of 12 months, provided a structured education programme to participants focussing on the avoidance of hypoglycaemia and the treatment of this if/when it occurred.
Study NCT03646929 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: MEP using standard facilitation technique
Description: measuring of MEP using standard facilitation technique according to the Guidelines of International Federation of Clinical Neurophysiology
Study NCT03646929 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: MEP using modified facilitation technique
Description: measuring of MEP using modified facilitation technique (application of additional 8-12x magnetic stimuli for arms and legs)
Study NCT04429347 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gabapentin
Description: Friday night: 1 capsule of 300 mg, Saturday night: 2 capsule of 300 mg (total 600 mg), Sunday night: choice of 1 or 2 capsule of 300 mg (total of 300 or 600 mg)
Study NCT04429347 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Friday night: 1 capsule, Saturday night: 2 capsule, Sunday night: choice of 1 or 2 capsules
Study NCT04429347 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tizanidine
Description: Friday night: 1 capsule of 2 mg, Saturday night: 2 capsule of 2 mg (total 4 mg), Sunday night: choice of 1 or 2 capsules of 2 mg (total of 2 or 4 mg)
Study NCT04422145 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Standard care
Description: Participants continue on their current diabetes care plan and are looked after by their usual diabetes care provider
Study NCT02586493 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Subjects will receive 1 inhalation once-daily until visit 2.
Study NCT02586493 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire
Description: ELLIPTA Inhaler Ease of Use Questionnaire is a four-point Likert scale. This questionnaire will be filled by investigator (designee) based on responses received from subject. Responses for the questionnaire are Very difficult, Difficult, Easy, Very easy. Subjects will be give either version A or B at Visit 2.
Study NCT03696342 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Zymar
Description: Gatifloxacin 0.3%. by Allergan, topical ophthalmic~1 drop, 3 times a day during the waking period in both eyes (at approximate intervals of 6 hours), for 7 days.
Study NCT00878904 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: epirubicin hydrochloride
Study NCT03249779 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Scrambler
Description: Scrambler Therapy is a specific form of electrical stimulation which has also been utilized in chronic neurogenic pain11. This modality of therapy differs from TENS in that the goal is to mediate the patient's perception of pain, rather than masking the peripheral pain signal. The results of this modality of treatment may be longer-lasting than TENS, presumably via reduction in central signal generation. Scrambler therapy works through C fibers to retrain the peripheral sensation in the area being treated. Further description of this technology is available at: International Patent PCT/IT2007/000647 and U.S. Patent No. 8,380,317. Literature search does not yield prior studies regarding efficacy of Scrambler therapy in treating RLS
Study NCT02416427 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Atorvastatin
Description: Atorvastatin will be administered at 80 mg/day for 3 weeks in the time window between diagnostic biopsy and curative surgery
Study NCT03601429 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Lactogyn
Description: capsules
Study NCT03601429 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: capsules
Study NCT00646737 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mycophenolate sodium
Description: Mycophenolate sodium
Study NCT01503528 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Motor Sparing Nerve Block
Description: Continuous Motor sparing knee block (60mL of 0.5% ropivacaine with 10 mg Morphine, 30 mg Ketorolac and 150 mcg of epinephrine as the initial bolus) initiated in the preoperative period in the block room as per the standard practice and continued until discharge. Patients will be connected to an Ambit infusion pump in the postoperative period set to deliver ropivacaine 0.2% at a basal infusion rate of 7 mL/Hr with patient controlled boluses of 5mL every hour for breakthrough pain.
Study NCT01503528 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Peri-articular Catheters
Description: 3 peri-articular catheters inserted at the end of surgery followed by periarticular infiltration with ropivacaine 0.2% and wound infusions will be continued until discharge using elastomeric devices.
Study NCT01452308 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Simtuzumab
Study NCT01998048 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Latarjet
Description: A diagnostic arthroscopy is performed before the Latarjet operation in general anaesthesia. In case of a significant Hill-Sachs defect an additional remplissage procedure may be performed according to surgeons' decision by inserting 1 to 2 more suture anchors according to surgeon's preference into the deepest portion of the Hill-Sachs defect and tying the infraspinatus tendon down to fill the bony defect. Thereafter an open Latarjet operation is performed using standard techniques described by Walch or de Beer. A deltopectoral incision is used. The coracoid process is osteotomized and ventrally prepared to bleeding bone. The coracoid process is then transferred through the middle of the subscapularis and re-attached on to the freshened neck of the glenoid, just medial to the joint line with two screws and washers, according to the surgeon's preference.
Study NCT01998048 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Bankart
Description: An arthroscopic Bankart operation is performed in general anaesthesia according to current practise (Provencher 2010). The intra-articular findings are recorded and the anteroinferior labrum and the IGHL are mobilized until subscapular muscle fibers can be seen. The IGHL complex is then re-attached to the freshened neck of the glenoid with 2 to 3 suture anchors according to surgeon's preference to re-create labral bumper and capsular tension. In case of a significant Hill-Sachs defect an additional remplissage procedure may be performed according to surgeon's decision by inserting 1 to 2 more suture anchors, according to surgeon's preference into the deepest portion of the Hill-Sachs defect and tying the infraspinatus tendon down to fill the bony defect.
Study NCT02357069 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Enbrel
Description: Etanercept
Study NCT02357069 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LBEC0101
Description: Etanercept
Study NCT02984384 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Acetylsalicylic acid
Description: The Aspirin intervention will be 81 mg enteral (by mouth, feeding tube or rectal) twice a day with no variation in dosing allowed.
Study NCT02984384 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Low Molecular Weight Heparin (LMWH)
Description: The LMWH intervention will be 30 mg enoxaparin subcutaneous (under the skin) twice a day with variations in dosing allowed, per the standard of care at sites, as needed for patients who are very obese or exhibit renal dysfunction.
Study NCT01554566 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: honey
Description: The subjects in the I/C group consumed 0.5 ml honey/kg/day in the first 12-week period (period 1) while the subjects in the C/I group did not receive honey as a control in period 1. After period 1 the subjects of each group exchanged their protocol for the following 12-week period (period 2).
Study NCT03523546 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cancer Episode Payment Model (CEM)
Description: Oncologists will be paid for an episode of care with the opportunity to receive a value based payment based on 6 quality metrics.
Study NCT00911508 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Left atrial ablation
Description: St. Jude: Livewire TC™ , Therapy™ Dual / Thermocouple, Safire,Therapy Cool Path~Biosense Webster: NAVI-STAR, NAVI-STAR/NAVI-STAR DS, Celsius Braided/Long Tip, NAVI-STAR™ and Celsius™ ThermoCool, NAVI-STAR® RMT, Celsius® RMT, ThermoCool® SF~Medtronic CryoCath LP: Freezor®/Freezor MAX®, Artic Front®, Cardiac Ablation System~Bard: Stinger~Boston Scientific: Blazer II RF/XP, Blazer RPM, Chilli II Cooled, SteeroCath
Study NCT00911508 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Rate or Rhythm Control Therapy
Description: Rate control: Metoprolol 50-100mg, Atenolol 50-100mg, Propranolol 40-80mg, Acebutolol 200-300mg, Carvedilol 6.25-25mg, Diltiazem 180-240mg, Verapamil 180-240mg, Digoxin 0.125-0.25mg~Rhythm control: Propafenone 450-625mg, Flecainide 200-300mg, Sotalol 240-320mg, Dofetilide 500-1000mcg, Amiodarone 200-400mg, Quinidine 600-900mg, Dronedarone 800mg
Study NCT04076280 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Sodium Watcher Program-Hypertension
Description: The Sodium Watcher Program -Hypertension intervention consists of 14 weeks of education \[4 weekly education sessions (45 minutes)followed by 5 bi-weekly sessions 5-20 minutes\] that will be held at the dyads' preferred time delivered to their homes using a video conferencing program through an iPad.
Study NCT04076280 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Usual Care
Description: Participants in the usual care group receive their routine medical and nursing care for hypertension that consists of a recommendation to follow a sodium restricted diet and take medications as ordered. Usual care consists of recommendations to follow a sodium restricted diet, but without explicit skills training including instructions on gradual adaptation to sodium restricted diet, follow-up of progress or provision of monitoring.
Study NCT01345162 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Ketorolac postoperative
Description: Ketorolac 10mg 1cp x 3/die
Study NCT01345162 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: postoperative Patrol
Description: acetaminophene 325mg+tramadol 37.5mg, 1cp x 3/die
Study NCT01345162 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: intraoperative analgesia
Description: ketorolac 30 mg iv
Study NCT01345162 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: intraoperative analgesia
Description: Tramadol 100 mg if Weight over 50 kg, 50 mg if weight below 50 kg
Study NCT04631835 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HS-10352
Description: Participants will receive single dose of HS-10352 on Day 1 of Cycle 1 followed by once daily from Day 8 of Cycle 1. (Cycle length: 35 days for Cycle 1 and 28 days for all other cycles). Participants will continue treatment until the end of the study in the absence of unacceptable toxicities and unequivocal disease progression.